Splenectomies are performed for patients with traumatic injuries, idiopathic thrombocytopenic purpura, thalassemia, hereditary spherocytosis, sickle cell anemia, and lymphoma. Although humans can survive without a spleen, there is an increased risk of overwhelming post-splenectomy infection (OPSI), and the estimated mortality rate has been reported up to 70% [10]. This significant risk for overwhelming infection can be explained by the absence of important host defense mechanisms provided by the spleen. The spleen is an intraperitoneal lymphoid organ that filters immune complexes from circulation thus protecting the body from microbial infection [11, 12]. It holds B-lymphocytes and mononuclear phagocytes that directly attack bacteria in addition to generating IgM that is responsible for eliminating encapsulated organisms including C. canimorsus.
C. canimorsus requires specific culture media for growth and has an incubation period of 1 to 14 days, with an average of 6 days, thus prolonging the ability to make a definitive microbiological diagnosis [1, 2]. Successful growth has been achieved with standard chocolate agar or Columbia agar with 5% sheep’s blood and aerobic 5–10% CO₂-enriched atmosphere at a temperature of 35℃ to 37℃. It does not grow on MacConkey agar [13]. In 11 patients with C. canimorsus meningitis, lumbar puncture revealed an elevated protein level in 9 patients with 8 labs below < 2.0 g/L, a decreased CSF glucose level (< 0.4 g/L) for most of the patients, and WBC count range of 0-6000 cells/µL and a neutrophilic predominance in 8 patients [13]. C. canimorsus can also be identified with a Gram stain that will test positive for Gram-negative rods.
Penicillin is regarded as the drug of choice for C. canimorsus infection [2]. C. canimorsus is also susceptible to imipenem, erythromycin, clindamycin, vancomycin, chloramphenicol, third generation cephalosporins, fluoroquinolones, rifampin, metronidazole, and doxycycline [2, 13]. Resistance has been reported with aztreonam, fosfomycin, polymyxin, and trimethoprim/sulfamethoxazole.
Sensorineural hearing loss (SNHL) is a known complication of acute meningitis and appears to be described often as a complication of capnocytophaga meningitis [4, 5, 14]. Even though our patient did not experience all the typical symptoms of meningitis, her SNHL was bilateral, acute, and coincided strongly with the development of this bacteremia. AKI was likely secondary to excessive use of NSAIDs during the viral prodrome and improved with aggressive IV hydration. The platelet count normalized with steroids, but in retrospect was likely secondary thrombocytopenia from bacteremia. Although a lumbar puncture was done and CSF profile/cultures/bacterial PCR were negative, they were taken almost a week after initiation of antibiotics with CNS (central nervous system) penetration. After otolaryngology evaluation, repeat MRI and lumbar puncture, no clear alternate cause has been determined thus far. Overall, the most likely scenario remains that her acute SNHL was related to a capnocytophaga meningitis complicating the bacteremia. Our patient has completed antimicrobial therapy. With audiology rehabilitation, she was able to improve her word recognition abilities, though she now requires hearing aids.